On Friday, Johnson & Johnson has informed that it has paid Rs. 25 lakhs each to three victims of its faulty Acetabular Surface Replacement (ASR) hip implants in Uttar Pradesh.

According to the statement of Uttar Pradesh Drug Licensing and Control Officer AK Jain, the pharmaceutical company has provided compensation to three patients who underwent revision surgeries for the faulty implants made by Johnson & Johnson. 

In May, the Delhi High Court has ordered Johnson & Johnson to make an interim payment of Rs. 25 lakhs each to 67 patients who underwent revision surgeries over faulty treatment. 

Mr. Jain continued that the Uttar Pradesh Drug Licensing and Control Authority was strictly following such complaints. 

Further details are awaited. 

Related Articles
Next Story
Going Viral
Economic Growth In India Is “Much Weaker Than Expected”- Explains IMF

Economic Growth In India Is “Much Weaker Than Expected”- Explains IMF

by Chandrani Sarkar September 13, 2019
On Thursday, the International Monetary Fund has said that the economic growth of India is “much weaker than expected” due to environmental and corporate regulatory variability and “lingering weakness” in some non-bank financial sectors.  The IMF spokesman Gerry Rice told sources at a press conference, “We will have a fresh set of numbers coming up, but the recent economic growth in India is much weaker than expected, mainly due to...